Publikationen

* Aufforderung an alle Studienleiter und ARO Mitglieder: Falls weitere Publikationen existieren senden Sie bitte die bibliographischen Angaben sowie möglichst ein PDF der Arbeit an das ARO Sekretariat.

Hodentumore:

Schmidberger, H., M. Bamberg. 1995 Therapieoptionen bei testikulären Seminomen in den frühen Stadien. Strahlentherapie und Onkologie 171 : 125-139.

Schmidberger, H. M. Bamberg, C. Meisner, J. Classen, C. Winkler, M. Hartmann, R. Templin, Th. Wiegel, W. Dornoff, D. Ross, H.-J. Thiel, C. Martini, W. Haase. 1997. Radiotherapy in stage IIA and IIB testicular seminoma with reduced portals: a prospective multicenter study. International Journal of Radiation Oncology Biology Physics 39: 321-326.

Bamberg, M., Schmidberger, H., Meisner, Ch., Classen, J., Souchon, R., Weinknecht, S., Schorcht, J., Walter, F., Engenhart-Cabillic, R., Schulz, U., Born, H., Flink, M. 1999. Radiotherapy for stage I and IIA/B testicular seminoma. International Journal of Cancer 83: 823-827.

Classen, J., Schmidberger, H., Meisner, CH., Winkler, C., Dunst, J., Souchon, R., Weissbach, L., Budach, V., Alberti, W., Bamberg, M. 2004. Paraaortic irradiation for stage I testicular seminoma: Results of A prospective study in 675 patients. Br. Journal of Cancer. 90: 2305-2311.

Classen J, Dieckmann K, Bamberg M, Souchon R, Kliesch S, Kuehn M, Loy V; German Testicular Cancer Study Group.
Radiotherapy with 16 Gy may fail to eradicate testicular intraepithelial neoplasia: preliminary communication of a dose-reduction trial of the German Testicular Cancer Study Group.
Br J Cancer. 2003 Mar 24;88(6):828-31.

Rektumkarzinom:

Sauer, R., Becker, H., Hohenberger, W., Rodel, C., Wittekind, C., Fietkau, R., Martus, P., Tschmelitsch, J., Hager, E., Hess, C.F., Karstens, J.H., Liersch, T., Schmidberger, H., Raab, R. German Rectal Cancer Study Group. 2004. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351: 1731-1740

Rödel C, Liersch T, Hermann RM, Arnold D, Reese T, Hipp M, Fürst A, Schwella N, Bieker M, Hellmich G, Ewald H, Haier J, Lordick F, Flentje M, Sülberg H, Hohenberger W, Sauer R.
Multicenter phase II trial of chemoradiation with oxaliplatin for rectal cancer. J Clin Oncol. 2007 Jan 1;25(1):110-7.

Fietkau R, Rödel C, Hohenberger W, Raab R, Hess C, Liersch T, Becker H, Wittekind C, Hutter M, Hager E, Karstens J, Ewald H, Christen N, Jagoditsch M, Martus P, Sauer R; German Rectal Cancer Study Group.
Rectal cancer delivery of radiotherapy in adequate time and with adequate dose is influenced by treatment center, treatment schedule, and gender and is prognostic parameter for local control: results of study CAO/ARO/AIO-94. Int J Radiat Oncol Biol Phys. 2007 Mar 15;67(4):1008-19. Epub 2006 Dec 29.

Sauer R, Fietkau R, Wittekind C, Rödel C, Martus P, Hohenberger W, Tschmelitsch J, Sabitzer H, Karstens JH, Becker H, Hess C, Raab R; German Rectal Cancer Group.Adjuvant vs. neoadjuvant radiochemotherapy for locally advanced rectal cancer:the German trial CAO/ARO/AIO-94. Colorectal Dis. 2003 Sep;5(5):406-15.

Sauer R, Fietkau R, Wittekind C, Martus P, Rödel C, Hohenberger W, Jatzko G,Sabitzer H, Karstens JH, Becker H, Hess C, Raab R.
Adjuvant versus neoadjuvant radiochemotherapy for locally advanced rectal cancer. A progress report of a phase-III randomized trial (protocol CAO/ARO/AIO-94). Strahlenther Onkol. 2001 Apr;177(4):173-81.

Kopf-Hals-Tumore:

Wendt TG, Grabenbauer GG, Rödel CM, Thiel HJ, Aydin H, Rohloff R, Wustrow TP, Iro H, Popella C, Schalhorn A. Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: a randomized multicenter study. J Clin Oncol. 1998 Apr;16(4):1318-24.

Semrau R, Mueller RP, Stuetzer H, Staar S, Schroeder U, Guntinas-Lichius O, Kocher M, Eich HT, Dietz A, Flentje M, Rudat V, Volling P, Schroeder M, Eckel HE. Efficacy of intensified hyperfractionated and accelerated radiotherapy and concurrent chemotherapy with carboplatin and 5-fluorouracil: updated results of a randomized multicentric trial in advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2006 Apr 1;64(5):1308-16.

Staar S, Rudat V, Stuetzer H, Dietz A, Volling P, Schroeder M, Flentje M, Eckel HE, Mueller RP.Intensified hyperfractionated accelerated radiotherapy limits the additional benefit of simultaneous chemotherapy--results of a multicentric randomized German trial in advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2001 Aug 1;50(5):1161-71.

Henke M, Laszig R, Rübe C, Schäfer U, Haase KD, Schilcher B, Mose S, Beer KT, Burger U, Dougherty C, Frommhold H.
Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial. Lancet. 2003 Oct 18;362(9392):1255-60.

Budach V, Stuschke M, Budach W, Baumann M, Geismar D, Grabenbauer G, Lammert I, Jahnke K, Stueben G, Herrmann T, Bamberg M, Wust P, Hinkelbein W, Wernecke KD. Hyperfractionated accelerated chemoradiation with concurrent fluorouracil-mitomycin is more effective than dose-escalated hyperfractionated accelerated radiation therapy alone in locally advanced head and neck cancer: final results of the radiotherapy cooperative clinical trials group of the German Cancer Society 95-06 Prospective Randomized Trial. J Clin Oncol. 2005 Feb 20;23(6):1125-35.

Maligne Lymphome:

Stuschke M, Hoederath A, Sack H, Pötter R, Müller RP, Schulz U, Karstens J, Makoski H. Extended field and total central lymphatic radiotherapy in the treatment of early stage lymph node centroblastic-centrocytic lymphomas: results of a prospective multicenter study. Study Group NHL-frühe Stadien. Cancer. 1997 Dec 15;80(12):2273-84.

Aderhautmetastasen:

Wiegel T, Bottke D, Kreusel KM, Schmidt S, Bornfeld N, Foerster MH, Hinkelbein W; German Cancer Society. External beam radiotherapy of choroidal metastases--final results of a prospective study of the German Cancer Society (ARO 95-08). Radiother Oncol. 2002 Jul;64(1):13-8.